Biopharmaceutical
Biotechnology
Cancer Prevention
Geron
$1.379876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.04 (-2.84%) As of 3:19 PM EDT today
-$0.04 (-2.84%) Today
Why Robinhood?
You can buy or sell Geron and other stocks, options, ETFs, and crypto commission-free!
About GERN
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Read More The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.
Employees
17
Headquarters
Menlo Park, California
Founded
1990
Market Cap
265.68M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
1.43M
High Today
$1.45
Low Today
$1.36
Open Price
$1.45
Volume
698.69K
52 Week High
$6.99
52 Week Low
$0.9547
Collections
Biopharmaceutical
Biotechnology
Cancer Prevention
Pharmaceutical
Health
Medical
Technology
GERN News
Price Paid on Robinhood
42% Lower
Right Now
52 Week Low
$0.9547
Average Price Paid
$2.37
52 Week High
$6.99
GERN Earnings
-$0.09
-$0.07
-$0.05
-$0.03
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Oct 31, After Hours